ZNF224 and chronic myelogenous leukemia, BCR-ABL1 positive: Starting from these data, we decided to investigate whether ZNF224 was involved in Imatinib-mediated transcriptional repression on c-Myc oncogene, which represents a key event in Imatinib responsiveness in CML [11–13].